Clinical Trials Directory

Trials / Unknown

UnknownNCT00963326

Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer

Morphological and Molecular Characterization of Tumors of the Aero-digestive Tract in Patients Who Have no Risk Factors Such as Alcohol, Smoking, or Occupation

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Centre Oscar Lambret · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood and tissue samples from patients with larynx cancer, pharynx cancer, or oral cavity cancer.

Detailed description

OBJECTIVES: Primary * Characterize, morphologically and molecularly, squamous cell carcinoma of the larynx, pharynx, or oral cavity in patients without high-risk factors, such as alcohol consumption, smoking, or occupation. Secondary * Study the impact parameters of morphology, molecular characteristics, and genomics on disease-free survival and overall survival of these patients. * Study the impact parameters of morphological, molecular, and genomic control in the tumor. * Assess, in advanced tumors, the risk of heterogeneity of morphological, molecular, and genomic control in the tumor. OUTLINE: This is a multicenter study. Blood, tumor tissue, and healthy tissue samples are collected before treatment begins. Patients are followed up every 3 months for 2 years (additional biopsies may be collected).

Conditions

Interventions

TypeNameDescription
OTHERlaboratory biomarker analysis

Timeline

Start date
2008-06-01
Primary completion
2010-07-01
First posted
2009-08-21
Last updated
2011-02-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00963326. Inclusion in this directory is not an endorsement.